This training of Tyroserleutide Phase III clinical trial in the First Affiliated Hospital of College of Medicine of Zhejiang University was held at Wuyang Hotel in Hangzhou on 3 September 2011, and around 30 experts from liver cancer field presented the conference nationally. The Chairman of Kangzhe Shenzhen Pharmaceutical Co., Ltd., Mr. Chen Hongbing introduced the background of Phase III research of Tyroserleutide, and our medical department also introduced the protocol, operation procedure and standardized procedure of the Tyroserleutide Phase III clinical trial. Medpace (the Clinical Research Organization of this clinical trial) also explained Good Clinical Practice rules for us. The success of this training played a leading role for us to successfully commence Tyroserleutide Phase III clinical trial in the whole country.